Guardant Health (GH) co-CEO reports RSU vesting, tax-share withholdings and over 2.1M shares held
Rhea-AI Filing Summary
Guardant Health, Inc. co-Chief Executive Officer Helmy Eltoukhy reported routine equity compensation activity involving restricted stock units and related common stock. On March 31 and April 1, 2026, multiple restricted stock unit awards converted into an aggregate of tens of thousands of shares of common stock at a $0.00 exercise price.
To cover associated tax obligations upon these vesting events, a total of 18,515 shares of common stock were retained by the company at prices of $92.37 and $91.15 per share, characterized as tax-withholding dispositions rather than open-market sales. Following these transactions, a revocable trust associated with Eltoukhy held 2,112,919 shares of common stock, and he directly held 68,011 restricted stock units. The filing reflects compensation-related vesting and tax withholding, not discretionary market trading.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 23,997 | $0.00 | -- |
| Exercise | Restricted Stock Units | 9,716 | $0.00 | -- |
| Exercise | Common Stock | 23,997 | $0.00 | -- |
| Exercise | Common Stock | 9,716 | $0.00 | -- |
| Tax Withholding | Common Stock | 17,087 | $91.15 | $1.56M |
| Exercise | Restricted Stock Units | 2,817 | $0.00 | -- |
| Exercise | Common Stock | 2,817 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,428 | $92.37 | $132K |
Footnotes (1)
- These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter: March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.